56 related articles for article (PubMed ID: 7949088)
1. A controlled trial of recombinant human erythropoietin after bone marrow transplantation.
Link H; Boogaerts MA; Fauser AA; Slavin S; Reiffers J; Gorin NC; Carella AM; Mandelli F; Burdach S; Ferrant A
Blood; 1994 Nov; 84(10):3327-35. PubMed ID: 7949088
[TBL] [Abstract][Full Text] [Related]
2. Clinical use of rHuEPO in bone marrow transplantation.
Klaesson S
Med Oncol; 1999 Apr; 16(1):2-7. PubMed ID: 10382935
[TBL] [Abstract][Full Text] [Related]
3. Preoperative erythropoietin in spine surgery.
Colomina MJ; Bagó J; Pellisé F; Godet C; Villanueva C
Eur Spine J; 2004 Oct; 13 Suppl 1(Suppl 1):S40-9. PubMed ID: 15197631
[TBL] [Abstract][Full Text] [Related]
4. Transfusion support for matched sibling allogeneic hematopoietic stem cell transplantation (1993-2010): factors that predict intensity and time to transfusion independence.
Griffith LM; VanRaden M; Barrett AJ; Childs RW; Fowler DH; Kang EM; Tisdale JF; Klein HG; Stroncek DF
Transfusion; 2019 Jan; 59(1):303-315. PubMed ID: 30362577
[TBL] [Abstract][Full Text] [Related]
5. Anemia and blood transfusion in the critically ill patient: role of erythropoietin.
Corwin HL
Crit Care; 2004; 8 Suppl 2():S42-4. PubMed ID: 15196323
[TBL] [Abstract][Full Text] [Related]
6. The impact of infused red blood cell volume on major and bidirectional ABO-mismatched bone marrow transplantation.
Araújo AB; Schmalfuss T; Furlan JM; Speransa D; Angeli MH; Sekine L; Franz JPM
Cytotherapy; 2024 May; ():. PubMed ID: 38795114
[TBL] [Abstract][Full Text] [Related]
7. Major incompatible red blood cell transfusions prior to bone marrow transplantation: Not worth the risk.
Haspel RL; McKenna DH
Br J Haematol; 2023 Dec; 203(5):889-890. PubMed ID: 37681639
[No Abstract] [Full Text] [Related]
8. Recombinant human erythropoietin does not affect several microvascular parameters in well-trained cyclists.
Birkhoff WAJ; Heuberger JAAC; Post TE; Gal P; Stuurman FE; Burggraaf J; Cohen AF
Physiol Rep; 2018 Dec; 6(24):e13924. PubMed ID: 30592183
[TBL] [Abstract][Full Text] [Related]
9. The efficacy of recombinant human erythropoietin in treatment chemotherapy induced anemia in children diagnosed with a solid cancer.
Hiradfar A; Banihosseinian M
Iran J Ped Hematol Oncol; 2014; 4(4):151-9. PubMed ID: 25598955
[TBL] [Abstract][Full Text] [Related]
10. Autologous bone marrow mononuclear cells to treat severe traumatic brain injury in children.
Cox CS; Notrica DM; Juranek J; Miller JH; Triolo F; Kosmach S; Savitz SI; Adelson PD; Pedroza C; Olson SD; Scott MC; Kumar A; Aertker BM; Caplan HW; Jackson ML; Gill BS; Hetz RA; Lavoie MS; Ewing-Cobbs L
Brain; 2024 May; 147(5):1914-1925. PubMed ID: 38181433
[TBL] [Abstract][Full Text] [Related]
11. Response to Haspel and McKenna 'Major incompatible red blood cell transfusions prior to bone marrow transplantation: Not worth the risk'.
Jarisch A; Bonig H
Br J Haematol; 2023 Dec; 203(5):891. PubMed ID: 37675578
[No Abstract] [Full Text] [Related]
12. Dynamics of Erythroferrone Response to Erythropoietin in Rats.
Xu P; Wong RSM; Krzyzanski W; Yan X
Front Pharmacol; 2022; 13():876573. PubMed ID: 35517793
[No Abstract] [Full Text] [Related]
13. Effect of erythropoietin on perioperative blood transfusions in primary total hip arthroplasty: A systematic review.
Abram D; Tran MH
Transfus Apher Sci; 2023 Aug; 62(4):103718. PubMed ID: 37173207
[TBL] [Abstract][Full Text] [Related]
14. Metabolomic Profiling of Recombinant Erythropoietin (rHuEpo) in Trained Caucasian Athletes.
Lima G; Shurlock J; Wang G; Karanikolou A; Sutehall S; Pitsiladis YP; D'Alessandro A
Clin J Sport Med; 2023 Sep; 33(5):e123-e134. PubMed ID: 36731031
[TBL] [Abstract][Full Text] [Related]
15. Novel Combination of Erythropoietin and Romiplostim to Treat Chemotherapy-Induced Anemia and Thrombocytopenia via Pharmacodynamic Interaction on Hematopoietic Stem and Progenitor Cells.
Fan X; Krzyzanski W; Wong RSM; Liu D; Yan X
ACS Pharmacol Transl Sci; 2023 Dec; 6(12):1884-1897. PubMed ID: 38093847
[TBL] [Abstract][Full Text] [Related]
16. Recombinant Human erythropoietin reduces viability of MCF-7 breast cancer cells from 3D culture without caspase activation.
ShujaaEdin HY; Al-Haj NA; Rasedee A; Alitheen NB; Kadir AA; How CW; Rahman HS; Abdullah AH
Saudi J Biol Sci; 2021 Apr; 28(4):2549-2557. PubMed ID: 33935571
[TBL] [Abstract][Full Text] [Related]
17. Asialo-rhuEPO as a Potential Neuroprotectant for Ischemic Stroke Treatment.
Kittur FS; Hung CY; Li PA; Sane DC; Xie J
Pharmaceuticals (Basel); 2023 Apr; 16(4):. PubMed ID: 37111367
[TBL] [Abstract][Full Text] [Related]
18. Reply: ABO nonidentical platelet transfusions and mortality.
Bookwalter DB; Reese SE; Bougie DW
Transfusion; 2024 May; 64(5):956-957. PubMed ID: 38733608
[No Abstract] [Full Text] [Related]
19. In response: ABO nonidentical platelet transfusions and mortality.
Blumberg N; Nguyen PL; Asante A; Masel D; Henrichs K; Refaai M; Heal J; Love T
Transfusion; 2024 May; 64(5):954-956. PubMed ID: 38733606
[No Abstract] [Full Text] [Related]
20. Autologous transfusion requirements in bone marrow harvest: results of the ATREMA study.
Valentini CG; Innocenti I; Pellegrino C; Draisci G; Teofili L;
Blood Transfus; 2024 Jan; 22(1):90-92. PubMed ID: 38276912
[No Abstract] [Full Text] [Related]
[Next] [New Search]
